CD4 c.1033G>A ;(p.E345K)

Variant ID: 12-6926373-G-A

NM_000616.4(CD4):c.1033G>A;(p.E345K)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Delivering co-stimulatory tumor necrosis factor receptor agonism for cancer immunotherapy: past, current and future perspectives.

Frontiers In Immunology
Dadas, Osman O; Ertay, Ayse A; Cragg, Mark S MS
Publication Date: 2023

Variant appearance in text: CD4: E345K
PubMed Link: 37180119
Variant Present in the following documents:
  • fimmu-14-1147467.pdf
View BVdb publication page



Therapeutic Antibodies: What Have We Learnt from Targeting CD20 and Where Are We Going?

Frontiers In Immunology
Marshall, Michael J E MJE; Stopforth, Richard J RJ; Cragg, Mark S MS
Publication Date: 2017

Variant appearance in text: CD4: E345K
PubMed Link: 29046676
Variant Present in the following documents:
  • Main text
  • fimmu-08-01245.pdf
View BVdb publication page